
Sign up to save your podcasts
Or


This week on BioTech Nation, Dr. Sam Clark, CEO of Terran Biosciences, discusses prodrugs—modified drugs that improve absorption and efficacy. Also, Terran Biosciences is developing non-hallucinogenic psychedelics by blocking the serotonin 2A receptor and manufacturing psychedelics like LSD and psilocybin for research. Dr. Clark highlights Terran's innovative, tech-inspired approach to rapidly develop affordable medications.
By Moira Gunn4.1
2929 ratings
This week on BioTech Nation, Dr. Sam Clark, CEO of Terran Biosciences, discusses prodrugs—modified drugs that improve absorption and efficacy. Also, Terran Biosciences is developing non-hallucinogenic psychedelics by blocking the serotonin 2A receptor and manufacturing psychedelics like LSD and psilocybin for research. Dr. Clark highlights Terran's innovative, tech-inspired approach to rapidly develop affordable medications.

21,968 Listeners

43,986 Listeners

32,105 Listeners

38,509 Listeners

30,798 Listeners

43,647 Listeners

26,247 Listeners

9,213 Listeners

468 Listeners

9,555 Listeners

66 Listeners

112,451 Listeners

16,356 Listeners

5,567 Listeners

16,001 Listeners